首页> 外国专利> METHOD OF TREATING PATIENTS WITH A HISTORY OF ATRIAL FIBRILLATION OR ATRIAL FLUTTER, OR CURRENT ATRIAL FIBRILLATION OR ATRIAL FLUTTER, PREVENTING CARDIOVASCULAR HOSPITALIZATION

METHOD OF TREATING PATIENTS WITH A HISTORY OF ATRIAL FIBRILLATION OR ATRIAL FLUTTER, OR CURRENT ATRIAL FIBRILLATION OR ATRIAL FLUTTER, PREVENTING CARDIOVASCULAR HOSPITALIZATION

机译:具有房颤或房扑史或当前房颤或房扑史的患者治疗方法,可预防心血管住院

摘要

The present invention relates to a method of treating patients having a history of atrial fibrillation or atrial flutter, or current atrial fibrillation or flutter, said method preventing cardiovascular hospitalization and comprising administrating dronedarone or a pharmaceutically acceptable salt thereof in the dose of 800 mg once or several times a day with a morning and an evening meal, wherein said medicament is contra-indicated for patients with severe heart failure, wherein severe heart failure is indicated by the following: worsening symptoms of heart failure at rest or with minimal exertion, current symptoms or history of congestive heart failure at rest, or symptoms of heart failure with minimal exertion within the last month, NYHA Class IV, NYHA Class III within the last month, recent decompensation as indicated by the need for hospitalization or intravenous therapy, recent decompensation requiring hospitalization or intravenous therapy for the treatment of heart failure. The present method allows to decrease the frequency of cardiovascular hospitalization and mortality in patients with associated risk factors.
机译:本发明涉及治疗具有心房颤动或心房扑动史或当前心房颤动或扑动史的患者的方法,所述方法防止心血管疾病住院并且包括以800mg的剂量施用决奈达隆或其药学上可接受的盐一次或一次。一天早上和晚上进餐几次,其中所述药物禁止用于患有严重心力衰竭的患者,其中严重心力衰竭的症状包括:休息时或最小程度的劳累时心力衰竭症状加重,当前症状或静息性充血性心力衰竭的病史,或最近一个月内用力最少的心力衰竭症状,最近一个月内的NYHA IV级,NYHA III类,需要住院或静脉内治疗的近期失代偿,最近失代偿住院或静脉注射治疗心力衰竭。本方法允许降低具有相关危险因素的患者的心血管住院频率和死亡率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号